Nnamdi Omenuko, Chidiebube Ugwu, Kalan Patel, Nneoma Ubah. "Comparative 3- and 5-year outcomes among first-line imatinib, dasatinib, and nilotinib in chronic myeloid leukemia: A real world analysis." Blood, 2025. doi:10.1182/blood-2025-7288